Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Drug Monitoring and Testing
  5. Drugs of Abuse Testing Systems
  6. 22911027

Abbott™ iCassette™ Dx Urine Drug Screen

Catalog No. 22911027
Change view
Click to view available options
Quantity:
25 Pack
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
22-911-027 25 Pack
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 22-911-027 Supplier Abbott™ Supplier No. IDCB1115011
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Rapidly screen for 11 illicit and prescription drugs

The iCassette Dx is easy to use and screens for 11 drugs on one device

  • FDA 510(k) Cleared and CLIA Waived
  • Integrated positive and negative reactive controls validate device performance
  • Simple procedure: collect and pipette to test — results in as little as 5 minutes
  • Test device remains in control of administrator
  • Requires only 5mL of specimen
  • Results can be photocopied for record keeping purposes
  • 12-18 Month shelf life
  • Results are easy to read
  • Room temperature storage

Specifications

Clia Complexity Waived
Detectable Analytes AMP, BAR, BZO, Cocaine (COC), MDMA, OPI, Oxycodone (OXY), Phencyclidine (PCP), PPX, TCA, THC (Cannabinoids)
Sample Type Urine
Type iCassette™ Dx Urine Drug Screen Panel
Quantity 25 Pack
Test Time 5 min.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.